Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Clinical trial NCT05118230 · COMPLETED
Trial details
- NCT number
- NCT05118230
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-09
- Primary completion
- 2024-07-20
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.